川芎化学成分及其在防治心血管疾病的研究进展
Research Progress on Chemical Constituents of Ligusticum chuanxiong Hort and Their Application in Prevention and Treatment of Cardiovascular Diseases
DOI: 10.12677/tcm.2024.1311419, PDF,    科研立项经费支持
作者: 周国寅, 黄浩高, 江子卉, 蒋欣妤：广西中医药大学研究生学院，广西 南宁；王庆高*：广西中医药大学第一附属医院心内科，广西 南宁
关键词: 心血管疾病；川芎；药理作用；化学成分；综述；Cardiovascular Disease； Ligusticum chuanxiong； Pharmacological Action； Chemical Composition； Review
摘要: 综述川芎在防治心血管系统疾病的药理作用及临床应用，以期能够为川芎的进一步研发应用提供相关依据。川芎是中医药临床辨证论治应用当中极为常见、组方广泛、使用最频繁的活血化瘀药之一，主要的功效有活血止痛、祛风除湿、行气等，外用可以促进人体经络气血循环、消肿止痛。川芎化学成分主要包含挥发油类、有机酸类、生物碱类以及多糖类等，在防治心血管系统的相关疾病方面具有独特应用。
Abstract: This paper reviews the pharmacological effects and clinical application of Ligusticum chuanxiong in the prevention and treatment of cardiovascular diseases, in order to provide relevant basis for the further development and application of Ligusticum chuanxiong. Chuanxiong is one of the most common, widely used and most frequently used drugs for promoting blood circulation and removing blood stasis in the clinical application of traditional Chinese medicine. Its main effects include promoting blood circulation and relieving pain, dispelling wind and removing dampness, and promoting qi circulation. External use can promote the circulation of qi and blood in human meridians, relieve swelling and relieve pain. The chemical constituents of Ligusticum chuanxiong mainly include volatile oils, organic acids, alkaloids and polysaccharides, which have unique applications in the prevention and treatment of cardiovascular diseases.
文章引用：周国寅, 黄浩高, 江子卉, 蒋欣妤, 王庆高. 川芎化学成分及其在防治心血管疾病的研究进展[J]. 中医学, 2024, 13(11): 2841-2849. https://doi.org/10.12677/tcm.2024.1311419

参考文献

[1] 钟赣生, 杨柏灿. 中药学[M]. 北京: 中国中医药出版社, 2021: 261.
[2] Huang, S., Chen, J., Liu, X., Xing, C., Zhao, L., Chan, K., et al. (2024) Evaluation of the Pharmaceutical Activities of Chuanxiong, a Key Medicinal Material in Traditional Chinese Medicine. Pharmaceuticals, 17, Article 1157. [Google Scholar] [CrossRef] [PubMed]
[3] Pu, Z.-H., Min, D., Liang, X. and Cheng, P. (2022) Total Alkaloids from the Rhizomes of Ligusticum striatum: A Review of Chemical Analysis and Pharmacological Activities. Natural Product Research, 36, 3489-3506. [Google Scholar] [CrossRef] [PubMed]
[4] Li, H., Zhuo, H., Yin, D., Li, W., Zhang, Y., Li, P., et al. (2021) Intra-Articular Injection of a Nanosuspension of Tetramethylpyrazine Dihydroxynaphthalenate for Stronger and Longer-Lasting Effects against Osteoarthritis. Journal of Biomedical Nanotechnology, 17, 1199-1207. [Google Scholar] [CrossRef] [PubMed]
[5] Li, J., Yu, J., Ma, H., Yang, N., Li, L., Zheng, D., et al. (2017) Intranasal Pretreatment with Z-Ligustilide, the Main Volatile Component of Rhizoma chuanxiong, Confers Prophylaxis against Cerebral Ischemia via Nrf2 and HSP70 Signaling Pathways. Journal of Agricultural and Food Chemistry, 65, 1533-1542. [Google Scholar] [CrossRef] [PubMed]
[6] Wang, W., Fang, S. and Xiong, Z. (2019) Protective Effect of Polysaccharide from Ligusticum chuanxiong Hort against H2O2-Induced Toxicity in Zebrafish Embryo. Carbohydrate Polymers, 221, 73-83. [Google Scholar] [CrossRef] [PubMed]
[7] 李芊, 吴效科. 川芎化学成分及药理作用研究新进展[J]. 化学工程师, 2020, 34(1): 62-64, 44.
[8] Yuan, X., Han, B., Feng, Z., Jiang, J., Yang, Y. and Zhang, P. (2020) Chemical Constituents of Ligusticum chuanxiong and Their Anti-Inflammation and Hepatoprotective Activities. Bioorganic Chemistry, 101, Article 104016. [Google Scholar] [CrossRef] [PubMed]
[9] Li, W., Tang, Y., Chen, Y. and Duan, J. (2012) Advances in the Chemical Analysis and Biological Activities of Chuanxiong. Molecules, 17, 10614-10651. [Google Scholar] [CrossRef] [PubMed]
[10] Kong, Q., Niu, Y., Feng, H., Yu, X., Wang, B., Liu, X., et al. (2024) Ligusticum Chuanxiong Hort.: A Review of Its Phytochemistry, Pharmacology, and Toxicology. Journal of Pharmacy and Pharmacology. [Google Scholar] [CrossRef] [PubMed]
[11] He, S., He, X., Pan, S. and Jiang, W. (2023) Exploring the Mechanism of Chuanxiong Rhizoma against Thrombosis Based on Network Pharmacology, Molecular Docking and Experimental Verification. Molecules, 28, Article 6702. [Google Scholar] [CrossRef] [PubMed]
[12] Yang, Y., Wu, Z., Xia, F., Zhang, H., Wang, X., Gao, J., et al. (2020) Characterization of Thrombin/Factor Xa Inhibitors in Rhizoma Chuanxiong through UPLC-MS-Based Multivariate Statistical Analysis. Chinese Medicine, 15, Article No. 93. [Google Scholar] [CrossRef] [PubMed]
[13] Li, L., Chen, H., Shen, A., Li, Q., Chen, Y., Chu, J., et al. (2018) Ligustrazine Inhibits Platelet Activation via Suppression of the Akt Pathway. International Journal of Molecular Medicine, 43, 575-582. [Google Scholar] [CrossRef] [PubMed]
[14] Sheu, J., Kan, Y., Hung, W., Lin, C. and Yen, M. (2000) The Antiplatelet Activity of Tetramethylpyrazine Is Mediated through Activation of NO Synthase. Life Sciences, 67, 937-947. [Google Scholar] [CrossRef] [PubMed]
[15] Zhang, Y., Ma, X., Guo, C., Wang, M., Kou, N., Qu, H., et al. (2016) Pretreatment with a Combination of Ligustrazine and Berberine Improves Cardiac Function in Rats with Coronary Microembolization. Acta Pharmacologica Sinica, 37, 463-472. [Google Scholar] [CrossRef] [PubMed]
[16] Lu, Z., Zhang, Y., Zhuang, P., Zhang, J., Zhou, H., Zhang, M., et al. (2015) Protective Effect of Suxiao Jiuxin Pill, a Traditional Chinese Medicine, against Acute Myocardial Ischemia in Dogs. BMC Complementary and Alternative Medicine, 15, Article No. 373. [Google Scholar] [CrossRef] [PubMed]
[17] Liu, X., Li, X., Ji, S., Cui, X. and Li, M. (2016) Screening of Bioactive Ingredients in Ligusticum chuanxiong Hort for Protection against Myocardial Ischemia. Cellular Physiology and Biochemistry, 40, 770-780. [Google Scholar] [CrossRef] [PubMed]
[18] Qian, W., Xiong, X., Fang, Z., Lu, H. and Wang, Z. (2014) Protective Effect of Tetramethylpyrazine on Myocardial Ischemia‐Reperfusion Injury. Evidence-Based Complementary and Alternative Medicine, 2014, Article 107501. [Google Scholar] [CrossRef] [PubMed]
[19] 赵润英, 郝伟, 孟祥军, 等. 阿魏酸川芎嗪后处理对大鼠心肌缺血再灌注损伤的影响[J]. 中国医科大学学报, 2012, 41(11): 1018-1021.
[20] 尚立芝, 韦大文, 王峰. 川芎嗪对心肌缺血再灌注损伤大鼠HSP25和p38MAPK表达的影响[J]. 中华中医药杂志, 2008, 23(10): 882-884.
[21] 杨明, 王朝平, 雷志强, 等. 川芎挥发油治疗心绞痛的网络药理学研究及实验验证[J]. 中国实验动物学报, 2024, 32(7): 867-878.
[22] Kim, E. and Rhyu, M. (2010) Synergistic Vasorelaxant and Antihypertensive Effects of Ligusticum wallichii and Angelica Gigas. Journal of Ethnopharmacology, 130, 545-551. [Google Scholar] [CrossRef] [PubMed]
[23] Bi, W., Yang, H., Liu, J., Cheng, T., Chen, C., Shih, C., et al. (2005) Inhibition of Cyclic Strain‐Induced Endothelin‐1 Secretion by Tetramethylpyrazine. Clinical and Experimental Pharmacology and Physiology, 32, 536-540. [Google Scholar] [CrossRef] [PubMed]
[24] Suzuki, A., Kagawa, D., Fujii, A., Ochiai, R., Tokimitsu, I. and Saito, I. (2002) Short-and Long-Term Effects of Ferulic Acid on Blood Pressure in Spontaneously Hypertensive Rats. American Journal of Hypertension, 15, 351-357. [Google Scholar] [CrossRef] [PubMed]
[25] Chen, Y., Lu, W., Yang, K., Duan, X., Li, M., Chen, X., et al. (2020) Tetramethylpyrazine: A Promising Drug for the Treatment of Pulmonary Hypertension. British Journal of Pharmacology, 177, 2743-2764. [Google Scholar] [CrossRef] [PubMed]
[26] Shao, Z., Li, J., Zhao, Z., Gao, C., Sun, Z. and Liu, X. (2010) Effects of Tetramethylpyrazine on Nitric Oxide/cGMP Signaling after Cerebral Vasospasm in Rabbits. Brain Research, 1361, 67-75. [Google Scholar] [CrossRef] [PubMed]
[27] Lubomirov, L.T., Papadopoulos, S., Filipova, D., Baransi, S., Todorović, D., Lake, P., et al. (2018) The Involvement of Phosphorylation of Myosin Phosphatase Targeting Subunit 1 (MYPT1) and MYPT1 Isoform Expression in NO/cGMP Mediated Differential Vasoregulation of Cerebral Arteries Compared to Systemic Arteries. Acta Physiologica, 224, e13079. [Google Scholar] [CrossRef] [PubMed]
[28] Yang, D., Dong, W., Yang, Y., Zeng, Y., Liu, Y., Dong, Z., et al. (2022) Tetramethylpyrazine Improves Monocrotaline-Induced Pulmonary Hypertension through the ROS/iNOS/PKG-1 Axis. Journal of Healthcare Engineering, 2022, Article 1890892. [Google Scholar] [CrossRef] [PubMed]
[29] Suzuki, A., Yamamoto, M., Jokura, H., Fujii, A., Tokimitsu, I., Hase, T., et al. (2007) Ferulic Acid Restores Endothelium-Dependent Vasodilation in Aortas of Spontaneously Hypertensive Rats. American Journal of Hypertension, 20, 508-513. [Google Scholar] [CrossRef] [PubMed]
[30] Senaphan, K., Kukongviriyapan, U., Sangartit, W., Pakdeechote, P., Pannangpetch, P., Prachaney, P., et al. (2015) Ferulic Acid Alleviates Changes in a Rat Model of Metabolic Syndrome Induced by High-Carbohydrate, High-Fat Diet. Nutrients, 7, 6446-6464. [Google Scholar] [CrossRef] [PubMed]
[31] Banecki, K.M.R.M. and Dora, K.A. (2023) Endothelin-1 in Health and Disease. International Journal of Molecular Sciences, 24, Article 11295. [Google Scholar] [CrossRef] [PubMed]
[32] Li, P., Peng, Y., Ma, Q., Li, Z. and Zhang, X. (2020) Study on the Formation of Antihypertensive Twin Drugs by Caffeic Acid and Ferulic Acid with Telmisartan. Drug Design, Development and Therapy, 14, 977-992. [Google Scholar] [CrossRef] [PubMed]
[33] Chen, Y., Duan, Y., Yang, X., Sun, L., Liu, M., Wang, Q., et al. (2015) Inhibition of ERK1/2 and Activation of LXR Synergistically Reduce Atherosclerotic Lesions in ApoE-Deficient Mice. Arteriosclerosis, Thrombosis, and Vascular Biology, 35, 948-959. [Google Scholar] [CrossRef] [PubMed]
[34] Hou, Y., Yang, J., Zhao, G. and Yuan, Y. (2004) Ferulic Acid Inhibits Endothelial Cell Proliferation through NO Down‐regulating ERK1/2 Pathway. Journal of Cellular Biochemistry, 93, 1203-1209. [Google Scholar] [CrossRef] [PubMed]
[35] Hou, Y., Yang, J., Zhao, G. and Yuan, Y. (2004) Ferulic Acid Inhibits Vascular Smooth Muscle Cell Proliferation Induced by Angiotensin II. European Journal of Pharmacology, 499, 85-90. [Google Scholar] [CrossRef] [PubMed]
[36] Yuan, Y., Yuan, R., Xin, Q., Miao, Y., Chen, Y., Gao, R., et al. (2024) Tetramethylpyrazine and Paeoniflorin Combination (TMP-PF) Inhibits Angiogenesis in Atherosclerosis via miR-126/VEGF/VEGFR2 Signaling Pathway. Journal of Future Foods, 4, 280-287. [Google Scholar] [CrossRef] 
[37] 马慧, 任卫英, 袁颖, 等. 川芎嗪激活核因子相关因子-2 (Nrf-2)抑制高脂饮食喂养的Apo-E基因敲除小鼠的动脉粥样硬化[J]. 复旦学报(医学版), 2015, 42(1): 90-95.
[38] Fu, R., Zhang, Y., Guo, Y., Zhang, Y., Xu, Y. and Chen, F. (2014) Digital Gene Expression Analysis of the Pathogenesis and Therapeutic Mechanisms of Ligustrazine and Puerarin in Rat Atherosclerosis. Gene, 552, 75-80. [Google Scholar] [CrossRef] [PubMed]
[39] Chen, J., Tian, J., Ge, H., Liu, R. and Xiao, J. (2017) Effects of Tetramethylpyrazine from Chinese Black Vinegar on Antioxidant and Hypolipidemia Activities in HepG2 Cells. Food and Chemical Toxicology, 109, 930-940. [Google Scholar] [CrossRef] [PubMed]
[40] Zhang, Y., Ren, P., Kang, Q., Liu, W., Li, S., Li, P., et al. (2017) Effect of Tetramethylpyrazine on Atherosclerosis and SCAP/SREBP‐1c Signaling Pathway in ApoE−/− Mice Fed with a High‐Fat Diet. Evidence-Based Complementary and Alternative Medicine, 2017, Article 3121989. [Google Scholar] [CrossRef] [PubMed]
[41] 陈启庭, 林洪, 陈利捷, 等. 基于GEO数据库联合网络药理学研究川芎-赤芍药对治疗动脉粥样硬化的药理过程及分子机制[J]. 中国医院用药评价与分析, 2024, 24(6): 655-661.
[42] Casella, S., Bielli, A., Mauriello, A. and Orlandi, A. (2015) Molecular Pathways Regulating Macrovascular Pathology and Vascular Smooth Muscle Cells Phenotype in Type 2 Diabetes. International Journal of Molecular Sciences, 16, 24353-24368. [Google Scholar] [CrossRef] [PubMed]
[43] Yang, W., Li, Y., Gao, H., Wu, X., Wang, X., Wang, X., et al. (2018) Protective Effect of the Ethanol Extract from Ligusticum chuanxiong Rhizome against Streptozotocin-Induced Diabetic Nephropathy in Mice. Journal of Ethnopharmacology, 227, 166-175. [Google Scholar] [CrossRef] [PubMed]
[44] Zhang, K., Fang, K., Wang, T., Xu, L., Zhao, Y., Wang, X., et al. (2021) Chemical Constituents from the Rhizome of Ligusticum chuanxiong Hort. and Their Nrf2 Inducing Activity. Chemistry & Biodiversity, 18, e2100302. [Google Scholar] [CrossRef] [PubMed]
[45] Hu, S., Chen, S., Li, Z., Wang, Y. and Wang, Y. (2020) Research on the Potential Mechanism of Chuanxiong Rhizoma on Treating Diabetic Nephropathy Based on Network Pharmacology. International Journal of Medical Sciences, 17, 2240-2247. [Google Scholar] [CrossRef] [PubMed]
[46] Zhang, H., Chen, H., Wu, X., Sun, T., Fan, M., Tong, H., et al. (2022) Tetramethylpyrazine Alleviates Diabetes-Induced High Platelet Response and Endothelial Adhesion via Inhibiting NLRP3 Inflammasome Activation. Phytomedicine, 96, Article 153860. [Google Scholar] [CrossRef] [PubMed]
[47] Liu, Y., Li, X., Jiang, S. and Ge, Q. (2018) Tetramethylpyrazine Protects against High Glucose-Induced Vascular Smooth Muscle Cell Injury through Inhibiting the Phosphorylation of JNK, p38MAPK, and ERK. Journal of International Medical Research, 46, 3318-3326. [Google Scholar] [CrossRef] [PubMed]
[48] Xiang, Y., Liu, Y., Xiao, F., Sun, X., Wang, X. and Wang, Y. (2020) 2,3,5,6-Tetramethylpyrazine Improves Diet-Induced Whole-Body Insulin Resistance via Suppressing White Adipose Tissue Lipolysis in Mice. Biochemical and Biophysical Research Communications, 532, 605-612. [Google Scholar] [CrossRef] [PubMed]
[49] 俞鹏飞, 薛凯元, 林立, 等. 基于网络药理学及分子对接分析当归-川芎药对治疗银屑病的作用机制[J]. 中国医院用药评价与分析, 2024, 24(8): 910-914.
[50] 董晋, 韩泽宇. 川芎活性物质阿魏酸乙酯联合有氧运动改善阿尔茨海默病大鼠的认知功能研究[J]. 中国食品卫生杂志, 2024, 36(6): 659-666.
[51] 左笑, 梁丽琦, 唐岚琦, 等. 川芎-天麻药对对偏头痛模型大鼠眶周机械痛阈及三叉神经节AMPK/TRPA1通路的影响[J]. 中医杂志, 2024, 65(7): 722-727.
[52] Hu, Y., Bi, X., Zhao, P., Zheng, H. and Huang, X. (2015) Cytotoxic Activities, SAR and Anti-Invasion Effects of Butylphthalide Derivatives on Human Hepatocellular Carcinoma SMMC7721 Cells. Molecules, 20, 20312-20319. [Google Scholar] [CrossRef] [PubMed]
[53] 李文庆, 彭成, 罗诗燕, 等. 川芎水煎液对DEN诱导肝纤维化大鼠肝功能及肝纤维化指标的影响[J]. 中药药理与临床, 2022, 38(6): 109-114.